Prevalence and Prognostic Impact of Metabolic Syndrome in Asymptomatic (Stage A and B Heart Failure) Patients-Reference-Cited by-同舟云学术

Prevalence and Prognostic Impact of Metabolic Syndrome in Asymptomatic (Stage A and B Heart Failure) Patients

Published:2016-04 Issue:3 Volume:14 Page:187-194
ISSN:1540-4196
Container-title:Metabolic Syndrome and Related Disorders
language:en
Short-container-title:Metabolic Syndrome and Related Disorders

Author:

La Carrubba Salvatore¹,Antonini-Canterin Francesco²,Fabiani Iacopo³,Colonna Paolo⁴,Pugliese Nicola Riccardo³,Caso Pio⁵,Conte Lorenzo³,Benedetto Frank⁶,Zito Concetta⁷,Citro Rodolfo⁸,Carerj Scipione⁷,Di Bello Vitantonio²,

Affiliation:

1. Ospedale Villa Sofia, Palermo, Italy.

2. Ospedale di Pordenone S. Maria degli Angeli-SSD Patologia Cardiovascolare ed Aterosclerosi, Pordenone, Italy.

3. Dipartimento di Patologia Medica, Chirurgica, Molecolare e dell'Area Critica, Università di Pisa, Pisa, Italy.

4. Azienda Ospedaliero Universitaria Policlinico—Bari U.O.C. Cardiologia Ospedaliera, Bari, Italy.

5. Azienda Ospedaliera Monaldi, Napoli, Italy.

6. UOC Cardiologia Clinica e Riabilitativa Azienda Ospedaliera “Bianchi-Melacrino-Morelli”, Reggio Calabria, Italy.

7. Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Messina, Messina, Italy.

8. AOU “San Giovanni di Dio e Ruggi d'Aragona”, Salerno, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/met.2015.0143

Reference50 articles.

1. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary

2. Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction

3. Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions

4. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

5. Burden of Systolic and Diastolic Ventricular Dysfunction in the Community

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modifiable lifestyle factors and their relationships with metabolic disorders among adults in Burkina Faso: Findings from the First National Survey;Journal of Public Health and Epidemiology;2023-07-31

2. Impact of Metabolic Syndrome and It's Components on Prognosis in Patients With Cardiovascular Diseases: A Meta-Analysis;Frontiers in Cardiovascular Medicine;2021-07-15

3. Prognostic Impact of Metabolic Syndrome in Patients With Heart Failure: A Meta-Analysis of Observational Studies;Frontiers in Cardiovascular Medicine;2021-06-24

4. The placenta and preeclampsia: villain or victim?;American Journal of Obstetrics and Gynecology;2021-03

5. The other side of the medallion in heart failure: Reverse metabolic syndrome;Nutrition, Metabolism and Cardiovascular Diseases;2020-10